tirzepatide cardiovascular outcome A comparison of the effects of and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial Tirzepatide vs Dulaglutide for Cardiovascular

The licensed medications for weight management include GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda)

*All sales are FINAL, so please ensure you've selected the correct version before purchase

Our provider-supervised weight loss program uses cutting-edge medications, like GLP-1 receptor agonists, to help you achieve sustainable results safely and effectively

Another swears by growth hormone peptides

Nakanishi H, Onose S, Kithara E, et al

Tirzepatide yields approximately 20% weight loss at its highest dose compared to a 7% weight loss through lifestyle interventions only in a double-blind, placebo-controlled study